Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis

By Kudo-Tanaka Eriko   Ohshima Shiro   Ishii Masaru   Mima Toru   Matsushita Masato   Azuma Naoto   Harada Yoshinori   Katada Yoshinori   Ikeue Hitomi   Umeshita-Sasai Mitsuko   Miyatake Kunio   Saeki Yukihiko  

Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. : 1627-1633

Springer Publishing Company

Access to resources Recommend Favorite

Anti-IL-1α autoantibodies in early rheumatoid arthritis

By Forslind Kristina   Svensson BjoÈrn   Svenson Morten   Bendtzen Klaus  

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 3, 2001-05 ,pp. : 167-168

Informa Healthcare

Access to resources Recommend Favorite

Anti‐cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population

By Kwok J. S. Y.   Hui K. H.   Lee T. L.   Wong W.   Lau Y. L.   Wong R. W. S.   Kim D. L.   Jones B. M.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 5, 2005-10 ,pp. : 359-366

Informa Healthcare

Access to resources Recommend Favorite

Early Referral and Outcome in Rheumatoid Arthritis

By Houssien D. A   Scott D. L  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 300-302

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of anti-Ro antibodies in rheumatoid arthritis

By Schneeberger Emilce   Citera Gustavo   Heredia Monica   Maldonado Cocco José  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 517-519

Springer Publishing Company

Access to resources Recommend Favorite